[Research Report] The smart pills market size is expected to grow from US$ 4,019.30 million in 2021 to US$ 9,061.29 million in 2028; it is estimated to record a CAGR of 12.3% from 2022 to 2028.
Analyst Perspective
The rise in the geriatric population, growing prevalence of lifestyle-related disorders such as obesity, gastric ulcers, and others, and increase in chronic disorders, including cancer, diabetes, and others are some of the factors that support the growth of smart pills market. Furthermore, growing research and development activities and funding for the development of the smart pill is one of the major factors fueling the smart pills market growth. Moreover, the rise in technological advances relating to smart pills, such as micro-cameras, miniaturization, availability of microprocessors, and others, offer lucrative opportunities for market growth in the future. With the rising cases of dementia and Alzheimer, there is an increased chance that patients may miss their doses of medication or may take the wrong administration, which increases the demand and need for smart pills. Hence, the smart pills market will experience growth in the coming years due to its growth need in the healthcare industry.
Market Overview
Smart pills are capsule-sized ingestible medical devices consisting of elements such as sensors, cameras, patches, and trackers that help in better diagnostics, patient monitoring, as well as targeted drug delivery. They are majorly available in the form of vitamin capsule-sized pills and possess a small wearable sensor patch, an application on a mobile device, and a provider portal. These unique devices can be easily swallowed and offer a non-invasive, thorough examination of the gastrointestinal (GI) tract and many other parts of the body. Smart pill technology helps patients and doctors to track their drug regimen compliance, thereby increasing patient adherence. Estimations suggest that this technology could save around US$100-US$300 billion yearly in the US. The primary drivers of the smart pills market are rising demand for minimally invasive surgical procedures and an increase in strategic collaborations & partnerships on smart pills. Also, increasing demand for drug delivery systems contributes to the growth of the smart pills market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Smart Pills Market: Strategic Insights
Market Size Value in US$ 4,019.30 Million in 2021 Market Size Value by US$ 9,061.29 million by 2028 Growth rate CAGR of 12.3% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Smart Pills Market: Strategic Insights
| Market Size Value in | US$ 4,019.30 Million in 2021 |
| Market Size Value by | US$ 9,061.29 million by 2028 |
| Growth rate | CAGR of 12.3% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Driver
Rising Demand for Minimally Invasive Surgical Procedures to Drive Global Smart Pills Market Growth
The geriatric population is highly susceptible to gastrointestinal disorders. A number of smart pills are being evaluated for potential application in therapeutics and diagnosing numerous acute and chronic diseases. Patients with chronic diseases who follow a specified dose of medication at the target site are anticipated to form a considerable customer base for advanced drug delivery products. Certain benefits offered by smart pills include advanced capsule endoscopy, easy remote patient monitoring, and targeted drug delivery. These factors result in the rising adoption of smart pills to treat gastrointestinal diseases or cancer patients. A growing shift in patient preference toward minimally invasive procedures for treatment is projected to drive the smart pills market growth. As per an article published in IEEE Access in February 2021, minimally invasive medicine has become mainstream due to its crucial clinical significance in delivering low-risk postoperative complications, limited blood loss, reduced postoperative recovery time, and small sizes of associated physiological tissue wounds. These factors result in the rising adoption of smart pills to treat gastrointestinal diseases or cancer patients.
The increasing demand for minimally invasive surgical procedures has led to innovative techniques, such as capsule endoscopy. Capsule endoscopy plays a crucial role in the early diagnosis and proper treatment of these disorders, along with hybrid imaging technologies and new component innovations, and is expected to replace traditional endoscopy methods due to its advantages, including ease of administration and detailed observation of the gastrointestinal tract. For instance, as per the University of Texas Health Science Center, deploying various colorectal cancer screening procedures, such as capsule endoscopy, improves adherence to screening. The university conducted a study comprising haphazardly assigned patients aged 50 to 75 and understood that capsule endoscopy gives better diagnostic results than CT colonography. Therefore, such factors are likely to boost the demand for smart pills, which in turn, drive the smart pills market growth in the forecast period.
Segmental Analysis
Based on disease indication, the smart pills market is categorized into gastrointestinal diseases, neurological disorders, cancer, inherited disorders, and other disease indications. In 2021, the gastrointestinal diseases segment held the largest market share. However, the cancer segment is estimated to register the highest CAGR during the forecast period. The Centers for Disease Control and Prevention (CDC) estimates that 60 to 70 million Americans are affected by gastrointestinal disorders each year, and tens of millions of endoscopic operations are performed as a result of it. Colonoscopies are also performed in millions of cases to diagnose or test for colorectal malignancies. Patients are uncomfortable with traditional, hard scopes used for these procedures, which might cause internal bruising or infection if they are reused on various patients. Thanks to smart pills, invasive procedures are no longer necessary: wireless connection allows real-time data to be transmitted, and developments in battery technology and onboard memory make them viable for long-term sensing from within the body.
Smart pills have transformed the diagnosis of gastrointestinal illness, and they may soon be able to replace traditional diagnostic methods like endoscopy. During a traditional procedure, an endoscopy probe is placed into a patient's esophagus, followed by the upper and lower gastrointestinal tract, for diagnostic purposes. The esophagus lining is in danger of perforation or tears, and the patient will experience discomfort during and after the treatment. However, a smart pill or wireless capsule endoscopy (WCE) can be eaten and manipulated to acquire images with minimum patient preparation, such as sedation. The built-in sensors allow the physician to measure all fluids and gases in the gut, providing a multidimensional image of the human body to the physician. Therefore, above mentioned factors support the growth of the segment in the smart pills market.
Regional Analysis
The Asia Pacific smart pills market was valued at US$ 488.75 million in 2021 and is projected to reach US$ 1,156.22 million by 2028; it is expected to grow at a CAGR of 13.1% during the forecast period. The Asia Pacific smart pills market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. Japan held the largest share of the Asia Pacific smart pills market in 2021. The growth of the smart pills market in the country is primarily driven by massive developments and financial aid that accelerate the adoption and acceptance of smart pills in the country. The growing prevalence of neurological diseases is likely to demand smart pill technology. For instance, in 2018, according to the health ministry, around 4.6 million people suffered from some form of dementia, and the total number is expected to soar to about 7.3 million people, i.e., one in five Japanese aged 65 or above by 2025. Also, the growing prevalence of gastrointestinal diseases in Japan fuel the demand for smart pills. As per the study ‘Trends in Gastrointestinal Diseases in Japan,’ the incidence of gastric cancer is high in East Asian countries, including Japan. It also reported that the incidence of gastroesophageal reflux disease (GERD) and IBD are continuously increasing.
Scientists and researchers have also helped the biotechnology and life science market to grow. Japan Society for the Promotion of Science (JSPS) estimated that nearly US$270 million (30 billion yen) of funds would be available to offer research grants which will further increase the development of new technologies by the researchers. Thus, the establishment of the plants and favorable funds & grants will support the smart pills market growth during the forecast period.
Key Player Analysis
The smart pills market analysis consists of players, such as CapsoVision, Inc.; Medtronic; Check-Cap; PENTAX Medical; Olympus Corporation; BodyCap; Otsuka America Pharmaceutical, Inc.; IntroMedic Co., Ltd; Jinshan Science & Technology.; and RF Co., Ltd. Among the players in the smart pills market, Medtronic and CapsoVision, Inc are the top two players owing to the diversified product portfolio offered.
Recent Developments
Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the smart pills market. A few recent key market developments are listed below:
- In January 2022, Novo Nordisk India has launched an oral formulation for an anti-diabetes drug available only as injections. The company claimed the new drug help better control blood sugar levels and weight in adults with type-2 diabetes. For this breakthrough, the company received the Prix Galien Award in 2020, a prestigious award in the industry. The drug was approved in 2020, by the Drugs Controller General of India.
- In December 2020, CapsoVision, Inc. achieved the International Standard Organization (ISO) 27001 security certification. The scope of the certification includes CapsoVision's headquarters and the company's CapsoCloud software.
- In August 2020, Otsuka America Pharmaceutical, Inc. announced that it had purchased the assets of Proteus Digital Health, Inc. (Proteus), including assets and intellectual property for its ingestible and wearable sensor technology.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Application, Disease Indication, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The smart pills market majorly consists of the players such as CapsoVision, Inc.; Medtronic.; Check-Cap; PENTAX Medical; Olympus Corporation; BodyCap.; Otsuka America Pharmaceutical, Inc.; IntroMedic; Jinshan Science & Technology (Group) Co., Ltd.; and RF Co., Ltd.
Smart pills are capsule-sized ingestible medical devices consisting of elements such as sensors, cameras, patches, and trackers that help in better diagnostics, patient monitoring, as well as targeted drug delivery. They are majorly available in the form of a vitamin capsule sized pill and possess small wearable sensor patch, an application on a mobile device, and a provider portal.
The factors that are driving and restraining factors that will affect the smart pills market in the coming years. Factors such as the increase in the demand for minimally invasive devices in the US, and the rise in the gastrointestinal disorders in U.S. characterize the growth in North America. In addition, rapid technological advancements in drug delivery are likely to boost the market for smart pills.
The global smart pills market based on application, is segmented into capsule endoscopy, drug delivery, and patient monitoring. In 2021, capsule endoscopy segment held largest market share. However, drug delivery is estimated to grow at the fastest CAGR of 13.4% during the forecast period.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Smart Pills Market – By Application
1.3.2 Global Smart Pills Market – By Disease Indication
1.3.3 Global Smart Pills Market – By End User
1.3.4 Global Smart Pills Market – By Geography
2. Smart Pills Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Smart Pills Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East & Africa – PEST Analysis
4.2.5 South & Central America – PEST Analysis
4.3 Expert Opinion
5. Smart Pills Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Demand for Minimally Invasive Surgical Procedures
5.1.2 Increase in Strategic Collaborations & Partnerships On Smart Pills
5.2 Market Restraints
5.2.1 High Cost of Smart Pill
5.3 Market Opportunities
5.3.1 Increasing Demand for Drug Delivery System
5.4 Future Trends
5.4.1 Remote Patient Monitoring Through Smart Pills
6. Smart Pills Market – Global Analysis
6.1 Global Smart Pills Market Revenue Forecast and Analysis
6.2 Global Smart Pills Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Smart Pills Market Analysis – By Application
7.1 Overview
7.2 Smart Pills Market, By Application, 2021 & 2028 (%)
7.3 Capsule Endoscopy
7.3.1 Overview
7.3.2 Capsule Endoscopy: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
7.3.3 Small Bowel Video Capsule Endoscopy
7.3.3.1 Overview
7.3.3.2 Small Bowel Video Capsule Endoscopy: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
7.3.4 Colon Capsule Endoscopy
7.3.4.1 Overview
7.3.4.2 Colon Capsule Endoscopy: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
7.3.5 Controllable Capsule Endoscopy
7.3.5.1 Overview
7.3.5.2 Controllable Capsule Endoscopy: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
7.3.6 Storable Capsule Endoscopy
7.3.6.1 Overview
7.3.6.2 Storable Capsule Endoscope: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
7.3.7 Other Capsule Endoscopy
7.3.7.1 Overview
7.3.7.2 Other Capsule Endoscopy: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Drug Delivery
7.4.1 Overview
7.4.2 Drug Delivery: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Patient Monitoring
7.5.1 Overview
7.5.2 Patient Monitoring: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
8. Smart Pills Market Revenue and Forecasts To 2028 – Disease Indication
8.1 Overview
8.2 Smart Pills Market Share by Disease Indication - 2021 & 2028 (%)
8.3 Gastrointestinal Diseases
8.3.1 Overview
8.3.2 Gastrointestinal Diseases: Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
8.4 Neurological Disorders
8.4.1 Overview
8.4.2 Neurological Disorders: Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
8.5 Cancer
8.5.1 Overview
8.5.2 Cancer: Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
8.6 Inherited Disorders
8.6.1 Overview
8.6.2 Inherited Disorders: Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
8.7 Other Disease Indications
8.7.1 Overview
8.7.2 Other Disease Indications: Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
9. Smart Pills Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 Smart Pills Market Share by End User - 2021 & 2028 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
9.4 Research Institutes
9.4.1 Overview
9.4.2 Research Institutes: Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
9.5 Home Healthcare
9.5.1 Overview
9.5.2 Home Healthcare: Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
10. Smart Pills Market – Regional Analysis
10.1 North America: Smart Pills Market
10.1.1 Overview
10.1.2 North America Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
10.1.3 North America Smart Pills Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.3.1 North America Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
10.1.4 North America Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
10.1.5 North America Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6 North America: Smart Pills Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3 US Smart Pills Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3.1 US Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.4 US Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.5 US Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Canada: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3 Canada Smart Pills Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3.1 Canada Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.4 Canada Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.5 Canada Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6.3 Mexico: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3 Mexico Smart Pills Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3.1 Mexico Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.4 Mexico Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.5 Mexico Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2 Europe: Smart Pills Market
10.2.1 Overview
10.2.2 Europe: Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe: Smart Pills Market, by Application, 2019-2028 (USD Million)
10.2.3.1 Europe: Smart Pills Market, by Capsule Endoscopy, 2019-2028 (USD Million)
10.2.4 Europe: Smart Pills Market, by Disease Indication, 2019-2028 (USD Million)
10.2.5 Europe: Smart Pills Market, by End-User, 2019–2028 (USD Million)
10.2.6 Europe: Smart Pills Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.3 Germany: Smart Pills Market, by Application, 2019-2028 (USD Million)
10.2.6.1.3.1 Germany: Smart Pills Market, by Capsule Endoscopy, 2019-2028 (USD Million)
10.2.6.1.4 Germany: Smart Pills Market, by Disease Indication, 2019-2028 (USD Million)
10.2.6.1.5 Germany: Smart Pills Market, by End-User, 2019–2028 (USD Million)
10.2.6.2 UK: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.1 Overview
10.2.6.2.2 UK: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.3 UK: Smart Pills Market, by Application, 2019-2028 (USD Million)
10.2.6.2.3.1 UK: Smart Pills Market, by Capsule Endoscopy, 2019-2028 (USD Million)
10.2.6.2.4 UK: Smart Pills Market, by Disease Indication, 2019-2028 (USD Million)
10.2.6.2.5 UK: Smart Pills Market, by End User, 2019–2028 (USD Million)
10.2.6.3 France: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.1 Overview
10.2.6.3.2 France: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.3 France: Smart Pills Market, by Application, 2019-2028 (USD Million)
10.2.6.3.3.1 France: Smart Pills Market, by Capsule Endoscopy, 2019-2028 (USD Million)
10.2.6.3.4 France: Smart Pills Market, by Disease Indication, 2019-2028 (USD Million)
10.2.6.3.5 France: Smart Pills Market, by End User, 2019-2028 (USD Million)
10.2.6.4 Spain: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.1 Overview
10.2.6.4.2 Spain: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.3 Spain: Smart Pills Market, by Application, 2019-2028 (USD Million)
10.2.6.4.3.1 Spain: Smart Pills Market, by Capsule Endoscopy, 2019-2028 (USD Million)
10.2.6.4.4 Spain: Smart Pills Market, by Disease Indication, 2019-2028 (USD Million)
10.2.6.4.5 Spain: Smart Pills Market, by End User, 2019-2028 (USD Million)
10.2.6.5 Italy: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.1 Overview
10.2.6.5.2 Italy: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.3 Italy: Smart Pills Market, by Application, 2019-2028 (USD Million)
10.2.6.5.3.1 Italy: Smart Pills Market, by Capsule Endoscopy, 2019-2028 (USD Million)
10.2.6.5.4 Italy: Smart Pills Market, by Disease Indication, 2019-2028 (USD Million)
10.2.6.5.5 Italy: Smart Pills Market, by End User, 2019-2028 (USD Million)
10.2.6.6 Rest of Europe: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.3 Rest of Europe: Smart Pills Market, by Application, 2019-2028 (USD Million)
10.2.6.6.3.1 Rest of Europe: Smart Pills Market, by Capsule Endoscopy, 2019-2028 (USD Million)
10.2.6.6.4 Rest of Europe: Smart Pills Market, by Disease Indication, 2019-2028 (USD Million)
10.2.6.6.5 Rest of Europe: Smart Pills Market, by End User, 2019-2028 (USD Million)
10.3 Asia-Pacific: Smart Pills Market Revenue and Forecasts To 2028
10.3.1 Overview
10.3.2 Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
10.3.3 Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.3.1 Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028, By Capsule Endoscopy (US$ Million)
10.3.4 Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028, By Disease Indication (US$ Million)
10.3.5 Asia Pacific: Smart Pills Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.3.6 Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028, By Country (%)
10.3.6.1 Japan: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 Japan: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.1.3 Japan: Smart Pills Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.1.3.1 Japan: Smart Pills Market Revenue and Forecasts to 2028, By Capsule Endoscopy (US$ Million)
10.3.6.1.4 Japan: Smart Pills Market Revenue and Forecasts to 2028, By Disease Indication (US$ Million)
10.3.6.1.5 Japan: Smart Pills Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2 China: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 China: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.2.3 China: Smart Pills Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.2.3.1 China: Smart Pills Market Revenue and Forecasts to 2028, By Capsule Endoscopy (US$ Million)
10.3.6.2.4 China: Smart Pills Market Revenue and Forecasts to 2028, By Disease Indication (US$ Million)
10.3.6.2.5 China: Smart Pills Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3 India Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.3.3 India: Smart Pills Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.3.3.1 India: Smart Pills Market Revenue and Forecasts to 2028, By Capsule Endoscopy (US$ Million)
10.3.6.3.4 India: Smart Pills Market Revenue and Forecasts to 2028, By Disease Indication (US$ Million)
10.3.6.3.5 India: Smart Pills Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4 South Korea: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.4.3 South Korea: Smart Pills Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.4.3.1 South Korea: Smart Pills Market Revenue and Forecasts to 2028, By Capsule Endoscopy (US$ Million)
10.3.6.4.4 South Korea: Smart Pills Market Revenue and Forecasts to 2028, By Disease Indication (US$ Million)
10.3.6.4.5 South Korea: Smart Pills Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5 Australia: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.5.3 Australia: Smart Pills Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.5.3.1 Australia: Smart Pills Market Revenue and Forecasts to 2028, By Capsule Endoscopy (US$ Million)
10.3.6.5.4 Australia: Smart Pills Market Revenue and Forecasts to 2028, By Disease Indication (US$ Million)
10.3.6.5.5 Australia: Smart Pills Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.6.3.1 Rest of Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028, By Capsule Endoscopy (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028, By Disease Indication (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Smart Pills Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.4 Middle East & Africa: Smart Pills Market Revenue and Forecasts To 2028
10.4.1 Overview
10.4.2 Middle East & Africa: Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
10.4.3 Middle East & Africa: Smart Pills Market, by Application, 2019-2028 (USD Million)
10.4.3.1 Middle East & Africa: Smart Pills Market, by Capsule Endoscopy, 2019-2028 (USD Million)
10.4.4 Middle East & Africa: Smart Pills Market, by Disease Indication, 2019-2028 (USD Million)
10.4.5 Middle East & Africa: Smart Pills Market, by End User, 2019-2028 (USD Million)
10.4.6 Middle East & Africa: Smart Pills Market Share by Country – 2021 & 2028, (%)
10.4.6.1 Saudi Arabia: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.1 Overview
10.4.6.1.2 Saudi Arabia: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.3 Saudi Arabia: Smart Pills Market, by Application, 2019-2028 (USD Million)
10.4.6.1.3.1 Saudi Arabia: Smart Pills Market, by Capsule Endoscopy, 2019-2028 (USD Million)
10.4.6.1.4 Saudi Arabia: Smart Pills Market, by Disease Indication, 2019-2028 (USD Million)
10.4.6.1.5 Saudi Arabia: Smart Pills Market, by End User, 2019–2028 (USD Million)
10.4.6.2 UAE: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.1 Overview
10.4.6.2.2 UAE: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.3 UAE: Smart Pills Market, by Application, 2019-2028 (USD Million)
10.4.6.2.3.1 UAE: Smart Pills Market, by Capsule Endoscopy, 2019-2028 (USD Million)
10.4.6.2.4 UAE: Smart Pills Market, by Disease Indication, 2019-2028 (USD Million)
10.4.6.2.5 UAE: Smart Pills Market, by End User, 2019–2028 (USD Million)
10.4.6.3 South Africa: Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 South Africa: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.3 South Africa: Smart Pills Market, by Application, 2019-2028 (USD Million)
10.4.6.3.3.1 South Africa: Smart Pills Market, by Capsule Endoscopy, 2019-2028 (USD Million)
10.4.6.3.4 South Africa: Smart Pills Market, by Disease Indication, 2019-2028 (USD Million)
10.4.6.3.5 South Africa: Smart Pills Market, by End User, 2019–2028 (USD Million)
10.4.6.4 Rest of Middle East and Africa: Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East and Africa: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.4.3 Rest of Middle East and Africa: Smart Pills Market, by Application, 2019-2028 (USD Million)
10.4.6.4.3.1 Rest of Middle East and Africa: Smart Pills Market, by Capsule Endoscopy, 2019-2028 (USD Million)
10.4.6.4.4 Rest of Middle East and Africa: Smart Pills Market, by Disease Indication, 2019-2028 (USD Million)
10.4.6.4.5 Rest of Middle East and Africa: Smart Pills Market, by End User, 2019–2028 (USD Million)
10.5 South and Central America Smart Pills Market Revenue and Forecasts To 2028
10.5.1 Overview
10.5.2 South and Central America: Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
10.5.3 South and Central America Smart Pills Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.5.3.1 South and Central America Smart Pills Market, By Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
10.5.4 South and Central America Smart Pills Market, By Disease Indication– Revenue and Forecast to 2028 (USD Million)
10.5.5 South and Central America: Smart Pills Market, by End User, 2019–2028 (USD Million)
10.5.6 South and Central America: Smart Pills Market Share by Country – 2021 & 2028, (%)
10.5.6.1 Brazil: Smart Pills Market- Revenue and Forecasts To 2028 (USD Million)
10.5.6.1.1 Overview
10.5.6.1.2 Brazil: Smart Pills Market- Revenue and Forecasts To 2028 (USD Million)
10.5.6.1.3 Brazil Smart Pills Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.5.6.1.3.1 Brazil Smart Pills Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.5.6.1.4 Brazil Smart Pills Market, By Disease Indication– Revenue and Forecast to 2028 (USD Million)
10.5.6.1.5 Brazil Smart Pills Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.5.6.2 Argentina: Smart Pills Market- Revenue and Forecasts To 2028 (USD Million)
10.5.6.2.1 Overview
10.5.6.2.2 Argentina: Smart Pills Market- Revenue and Forecasts To 2028 (USD Million)
10.5.6.2.3 Argentina Smart Pills Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.5.6.2.3.1 Argentina Smart Pills Market, By Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.4 Argentina Smart Pills Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.5 Argentina Smart Pills Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.5.6.3 Rest of South and Central America: Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South and Central America: Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
10.5.6.3.3 Rest of South and Central America Smart Pills Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.5.6.3.3.1 Rest of South and Central America Smart Pills Market, By Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.4 Rest of South and Central America Smart Pills Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.5 Rest of South and Central America Smart Pills Market, By End User – Revenue and Forecast to 2028 (USD Million)
11. Impact of COVID-19 Pandemic on Global Smart Pills Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Smart Pills Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Smart Pills Market, 2021-2028
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 CapsoVision, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Check-Cap
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 PENTAX Medical
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Olympus Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BodyCap
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Otsuka Holdings Co., Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 IntroMedic Co., Ltd.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 JINSHAN Science & Technology
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 RF Co., Ltd.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Smart Pills Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. US Smart Pills Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. US Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 7. US Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 8. US Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Smart Pills Market, by Application-Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Smart Pills Market, by Capsule Endoscopy -Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Smart Pills Market, by Disease Indication -Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Smart Pills Market, by Application -Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Smart Pills Market, by Capsule Endoscopy -Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Smart Pills Market, by Disease Indication -Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Europe Smart Pills Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 18. Europe Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 19. Europe Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 20. Europe Smart Pills Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 21. Germany Smart Pills Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 22. Germany Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 23. Germany Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 24. Germany Smart Pills Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 25. UK Smart Pills Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 26. UK Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 27. UK Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 28. UK Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 29. France Smart Pills Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 30. France Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 31. France Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 32. France Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 33. Spain Smart Pills Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 34. Spain Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 35. Spain Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 36. Spain Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 37. Italy Smart Pills Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 38. Italy Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 39. Italy Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 40. Italy Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 41. Rest of Europe Smart Pills Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 42. Rest of Europe Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 43. Rest of Europe Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 44. Rest of Europe Smart Pills Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 45. Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 46. Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028, By Capsule Endoscopy (US$ Million).
Table 47. Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028, By Disease Indication (US$ Million).
Table 48. Asia Pacific: Smart Pills Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 49. Japan: Smart Pills Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 50. Japan: Smart Pills Market Revenue and Forecasts to 2028, By Capsule Endoscopy (US$ Million).
Table 51. Japan: Smart Pills Market Revenue and Forecasts to 2028, By Disease Indication (US$ Million).
Table 52. Japan: Smart Pills Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 53. China: Smart Pills Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 54. China: Smart Pills Market Revenue and Forecasts to 2028, By Capsule Endoscopy (US$ Million).
Table 55. China: Smart Pills Market Revenue and Forecasts to 2028, By Disease Indication (US$ Million).
Table 56. China: Smart Pills Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 57. India: Smart Pills Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 58. India: Smart Pills Market Revenue and Forecasts to 2028, By Capsule Endoscopy (US$ Million).
Table 59. India: Smart Pills Market Revenue and Forecasts to 2028, By Disease Indication (US$ Million).
Table 60. India: Smart Pills Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 61. South Korea: Smart Pills Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 62. South Korea: Smart Pills Market Revenue and Forecasts to 2028, By Capsule Endoscopy (US$ Million).
Table 63. South Korea: Smart Pills Market Revenue and Forecasts to 2028, By Disease Indication (US$ Million).
Table 64. South Korea: Smart Pills Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 65. Australia: Smart Pills Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 66. Australia: Smart Pills Market Revenue and Forecasts to 2028, By Capsule Endoscopy (US$ Million).
Table 67. Australia: Smart Pills Market Revenue and Forecasts to 2028, By Disease Indication (US$ Million).
Table 68. Australia: Smart Pills Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 70. Rest of Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028, By Capsule Endoscopy (US$ Million).
Table 71. Rest of Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028, By Disease Indication (US$ Million).
Table 72. Rest of Asia Pacific: Smart Pills Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 73. Middle East & Africa Smart Pills Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 74. Middle East & Africa Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 75. Middle East & Africa Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 76. Middle East & Africa Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 77. Saudi Arabia Smart Pills Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 78. Application
Table 79. Saudi Arabia Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 80. Capsule Endoscopy
Table 81. Saudi Arabia Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 82. Disease Indication
Table 83. Saudi Arabia Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 84. End User
Table 85. UAE Smart Pills Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 86. UAE Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 87. UAE Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 88. UAE Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 89. South Africa Smart Pills Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 90. South Africa Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 91. South Africa Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 92. South Africa Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 93. Rest of Middle East and Africa Smart Pills Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 94. Application
Table 95. Rest of Middle East and Africa Smart Pills Market, by Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 96. Capsule Endoscopy
Table 97. Rest of Middle East and Africa Smart Pills Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 98. Disease Indication
Table 99. Rest of Middle East and Africa Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 100. End User
Table 101. South and Central America Smart Pills Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 102. South and Central America Smart Pills Market, By Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 103. South and Central America Smart Pills Market, By Disease Indication– Revenue and Forecast to 2028 (USD Million)
Table 104. South and Central America Smart Pills Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 105. Brazil Smart Pills Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 106. Brazil Smart Pills Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 107. Brazil Smart Pills Market, By Disease Indication– Revenue and Forecast to 2028 (USD Million)
Table 108. Brazil Smart Pills Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 109. Argentina Smart Pills Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 110. Argentina Smart Pills Market, By Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 111. Argentina Smart Pills Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)
Table 112. Argentina Smart Pills Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of South and Central America Smart Pills Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of South and Central America Smart Pills Market, By Capsule Endoscopy – Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of South and Central America Smart Pills Market, By Disease Indication Revenue and Forecast to 2028 (USD Million)
Table 116. Rest of South and Central America Smart Pills Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 117. Recent Inorganic Growth Strategies in the Smart Pills Market
Table 118. Recent Organic Growth Strategies in the Smart Pills Market
Table 119. Glossary of Terms, Smart Pills Market
LIST OF FIGURES
Figure 1. Smart Pills Market Segmentation
Figure 2. Smart Pills Market Segmentation, By Region
Figure 3. Global Smart Pills Market Overview
Figure 4. Capsule Endoscopy Segment Held Largest Share by Application in Smart Pills Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Smart Pills Market, By Geography (US$ Million)
Figure 7. Global Smart Pills Market- Leading Country Markets (US$ Million)
Figure 8. Global Smart Pills Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Smart Pill Market Impact Analysis of Drivers and Restraints
Figure 15. Global Smart Pills Market – Revenue Forecast and Analysis – 2021- 2028
Figure 16. Global Smart Pills Market – By Geography Forecast and Analysis – 2021- 2028.
Figure 17. Market Positioning of Key Players in Global Smart Pills Market
Figure 18. Smart Pills Market, by Application, 2021 & 2028 (%)
Figure 19. Capsule Endoscopy: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Small Bowel Video Capsule Endoscopy: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Colon Capsule Endoscopy: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Controllable Capsule Endoscopy: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Storable Capsule Endoscope: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Other Capsule Endoscopy: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Drug Delivery: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Patient Monitoring: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Smart Pills Market Share by Disease Indication - 2021 & 2028 (%)
Figure 28. Gastrointestinal Diseases: Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29. Neurological Disorders: Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Cancer: Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Inherited Disorders: Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Other Disease Indications: Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Smart Pills Market Share by End User - 2021 & 2028 (%)
Figure 34. Hospitals and Clinics: Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35. Research Institutes: Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36. Home Healthcare: Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 37. North America: Smart Pills Market, by Key Country – Revenue (2021) (USD Million)
Figure 38. North America Smart Pills Market Revenue and Forecast to 2028 (USD Million)
Figure 39. North America: Smart Pills Market, by Country, 2021 & 2028 (%)
Figure 40. US: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Canada: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Mexico: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. Europe: Smart Pills Market, by Key Country – Revenue (2021) (USD Million)
Figure 44. Europe Smart Pills Market Revenue and Forecast to 2028 (USD Million)
Figure 45. Europe: Smart Pills Market, by Country, 2021 & 2028 (%)
Figure 46. Germany: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. UK: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. France: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Spain: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. Italy: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. Rest of Europe: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
Figure 52. Asia Pacific Smart Pills Market Overview, by Country (2021)
Figure 53. Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 54. Asia Pacific: Smart Pills Market Revenue and Forecasts to 2028, By Country (%)
Figure 55. Japan: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 56. China: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 57. India: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 58. South Korea: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 59. Australia: Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 60. Rest of Asia Pacific: Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. Middle East & Africa: Smart Pills Market, by Key Country – Revenue (2021) (USD Million)
Figure 62. Middle East & Africa Smart Pills Market Revenue and Forecast to 2028 (USD Million)
Figure 63. Middle East & Africa: Smart Pills Market Share by Country – 2021 & 2028, (%)
Figure 64. Saudi Arabia: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. UAE: Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. South Africa: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. Rest of Middle East and Africa: Smart Pills Market – Revenue and Forecast to 2028 (USD Million)
Figure 68. South and Central America: Smart Pills Market, By Key Country – Revenue (2021) (USD Million)
Figure 69. South and Central America: Smart Pills Market- Revenue and Forecasts To 2028 (USD Million)
Figure 70. South and Central America: Smart Pills Market Share by Country – 2021 & 2028, (%)
Figure 71. Brazil: Smart Pills Market- Revenue and Forecasts To 2028 (USD Million)
Figure 72. Argentina: Smart Pills Market- Revenue and Forecasts To 2028 (USD Million)
Figure 73. Rest of South and Central America: Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
Figure 74. Impact of COVID-19 Pandemic in North American Country Markets
Figure 75. Impact of COVID-19 Pandemic in European Country Markets
Figure 76. Impact of COVID-19 Pandemic in Asia Pacific Countries
Figure 77. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 78. Impact Of COVID-19 Pandemic in South and Central America Country Markets
Figure 79. Growth Strategies in the Smart Pills Market, 2021-2028
The List of Companies - Smart Pills Market
- CapsoVision, Inc.
- Given Imaging, Inc.
- Check-Cap
- PENTAX Medical
- Olympus
- BodyCap
- Otsuka America Pharmaceutical, Inc.
- IntroMedic
- Jinshan Science & Technology (Group) Co., Ltd.
- RF Co., Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Smart Pills Market
Mar 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Mar 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Mar 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)